Clinical trial

The Safety and Effectiveness of Methylprednisolone in the Treatment of…

NCT00000741 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Withdrawn

Key facts

NCT number NCT00000741
Title The Safety and Effectiveness of Methylprednisolone in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Children With AIDS
Official title A Controlled Randomized Trial to Study the Efficacy of Adjunctive Methylprednisolone for the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Pediatric AIDS Patients
Lead sponsor National Institute of Allergy and Infectious Diseases (NIAID), NIH
Collaborators Upjohn Industry
Status Withdrawn
Phase Phase 3
Study type Interventional
Conditions Pneumonia, Pneumocystis Carinii, HIV Infections
Intervention type Drug
Interventions Methylprednisolone
Enrollment 0
First posted Aug 31, 2001
Last update posted Nov 4, 2021
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies